IBA Dosimetry Showcases Blue Phantom Radiation Therapy Commissioning Innovation at AAPM
(Due to the length of this URL, it may be necessary to copy and pastethis hyperlink into your Internet browser's URL address field. Remove thespace if one exists.)
Linear diode array technology is used by medical physicists to gain moredata in a dramatically shortened amount of time. Compared to traditionalmethods, where only one detector measures the dose output of the linearaccelerator in a lengthy point-by-point approach, the LDA-99SC measures anentire dose profile at once; a full 40cm field profile is measured in lessthan one second. Exceptionally high data accuracy is accomplished by thehighest detector spacing resolution available, in combination with anadvanced, multi-scanning routine that performs automatic shifts andmeasurements of the LDA-99SC with an accuracy down to 0.5 mm. Time-consumingbeam measurements can now be completed up to three times faster, resulting inaccelerated initial commissioning and annual linear accelerator qualityassurance checks. This new technology enables medical physicists to spendconsiderably less time on routine data acquisition, and more time on actualclinical work.
"I have been using IBA's water phantom for five years, and based on ourgood experience with the product and the company's service we have recentlydecided to upgrade to the new Blue Phantom," said Joe Presser M.Sc., SouthNassau Communities Hospital, Oceanside, NY. "I am especially impressed withthe overall accuracy and speed that the new phantom and acceptance softwareprovides."
Launched in 2009, the Blue Phantom is the only modular, 3D waterphantom for commissioning, testing and regular quality assurance in radiationtherapy. IBA Dosimetry, dedicated to providing solutions for medicalphysicists around the world, has introduced a range of accessories, such asthe LDA-99SC and acceptance software, to further optimize commissioning work.
"At IBA Dosimetry, we respect the important work performed by medicalphysicists around the world every day, and their dedication to radiationtherapy accuracy and safety," said Ralf Schira, vice president, marketing atIBA Dosimetry. "With the new features of the Blue Phantom, in particularthe LDA-99SC, we continue our long history of providing trendsetting andmarket leading solutions to over 3,500 medical physics customers worldwidethat enable them to execute their work in the fastest, most accurate and mostreliable way."
About IBA Dosimetry and IBA group
IBA Dosimetry offers a full range of innovative solutions forradiotherapy, radiodiagnostics, calibration service and imaging markers. Itsmeasuring instruments and software enable medical physicists and radiologiststo perform the necessary quality assurance and calibration procedures.
IBA develops and markets leading-edge technologies, pharmaceuticals andtailor-made solutions for healthcare with a focus on cancer diagnosis andtherapy. Leveraging on its scientific expertise, IBA is also active in thefield of industrial sterilization and ionization. Listed on the pan-Europeanstock exchange EURONEXT, IBA is included in the BelMid Index. (IBA: ReutersIBAB.BR and Bloomberg IBAB.BB).
Please visit http://www.iba-dosimetry.com andhttp://www.iba-worldwide.com for more information about IBA Dosimetry and IBAgroup.Media contact: Ralf Schira VP Marketing, IBA Dosimetry Tel.: +49-9128-607-0 Email: email@example.com
SOURCE IBA Dosimetry
You May Also Like